A Look Inside The White House’s First Cannabis Products Enforcement Policy Meeting
The White House has held the first in a series of scheduled meetings with cannabis industry and research stakeholders to discuss a proposed new enforcement policy for CBD products. Representatives of the Office of Information and Regulatory Affairs (OIRA) under the White House Office of Management and Budget (OMB) spoke with David Heldreth, CEO of […]
White House Schedules More Meetings On Cannabis Product Enforcement Policy From FDA For This Week
The White House now scheduled a total of four meetings with cannabis industry and research stakeholders this week to discuss a proposed enforcement policy for CBD products. The Office of Information and Regulatory Affairs (OIRA) under the White House Office of Management and Budget (OMB) announced earlier this month that it plans to review yet-unpublished guidance […]
White House schedules cannabis enforcement meeting (Newsletter: March 27, 2026)
Feds list immigrants who possessed marijuana as “worst of the worst”; ID medical cannabis ballot; OH hemp THC drink push; LA psychedelics Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana Moment possible… […]
White House Schedules Meeting On Cannabis Products Enforcement Policy For Next Week
The White House has scheduled a meeting for next week with a cannabis biotechnology company executive regarding a proposed enforcement policy for CBD products. The Office of Information and Regulatory Affairs (OIRA) under the White House Office of Management and Budget (OMB) announced earlier this month that it plans to review yet-unpublished guidance titled “Cannabidiol […]
Marijuana Reform Isn’t This White House’s Drug Policy Priority
Sara Carter, the former investigative journalist and Fox News contributor now serving as White House drug czar, has spent her early months emphasizing fentanyl, trafficking and addiction, not marijuana reform. Cannabis may still move through federal channels, but it is clearly not the part of drug policy this White House wants to lead with. If […]
FDA Submits New Cannabis Products Enforcement Policy For White House Review
The Food and Drug Administration (FDA) has submitted a proposed cannabis products enforcement policy to the White House for review that concerns regulatory issues specifically related to CBD. The White House Office of Management and Budget’s (OMB) Office of Information and Regulatory Affairs (OIRA) posted a notice that it received the submission from FDA, which […]